Thursday, September 21, 2017 8:30:33 PM
PR Newswire
TAMPA, FL, April 3, 2014
TAMPA, FL, April 3, 2014 /PRNewswire/ - iMD Companies, Inc. (OTC:ICBU). The Company announced it has retained KBL LLP, a New York City based accounting firm, to assist the Company in moving forward with its planned expansion. This step and others to follow will be adding to the stability and capability of the company, providing a steady platform for future growth.
KBL, LLP, a CPA firm that is registered with the Public Company Accounting Oversight Board has been retained to audit iMD Companies' financial statement through 2013. This is an initial step for the purpose of the Company's shares being quoted on a more senior exchange. Audit work will be beginning concurrent with this release, and will be completed consistent with KBL's normal work schedule.
"iMD Companies is very pleased to be completing this next step in its growth, as it brings the company one step closer to being able to provide transparency to its investors as well as execute on its business plan," stated Rick Wilson, Chairman of iMD Companies. "As we grow through strategic and value added acquisitions, it is our plan to increase our footprint in the rapidly expanding marijuana sector, further increasing shareholder value".
About KBL LLP:
Based in New York City, KBL, LLP (www.kbl.com) is a leading Certified Public Accounting and Business Advisory Services firm focused on meeting the needs of emerging businesses. The firm has a multi-disciplined practice that cultivates an environment of strategic problem solvers and business innovators, always keeping you, our client, ahead of the curve.
As accountants and advisors, KBL serves a diverse client base of privately and publicly held entities across the United States and the world. The firm creates personalized approaches that are based on each client's unique goals, business culture, and dynamics. We then assemble the specific solutions, procedures and people necessary to assist our clients in achieving their objectives.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM